Emerald Bioscience, Inc. Contracts & Agreements

Skye Bioscience, Inc. Amended and Restated Omnibus Incentive Plan (Filed With SEC on November 7, 2024)

Employment Agreement (Filed With SEC on September 4, 2024)

2024 Inducement Equity Incentive Plan (Filed With SEC on August 9, 2024)

Form of Stock Option Grant (Filed With SEC on August 9, 2024)

Form of Restricted Stock Unit (Filed With SEC on August 9, 2024)

Form of Securities Purchase Agreement, dated as of January 29, 2024, by and among Skye Bioscience, Inc. and the Investors named therein (Filed With SEC on May 10, 2024)

Agreement and Plan of Merger and Reorganization (Filed With SEC on March 22, 2024)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 22, 2024)

Amendment to Common Stock Purchase Warrants (Filed With SEC on March 13, 2024)

Form of Securities Purchase Agreement, dated as of March (Filed With SEC on March 13, 2024)

Form of Registration Rights Agreement, dated as of March (Filed With SEC on March 13, 2024)

Form of Pre-Funded Warrant (Filed With SEC on January 29, 2024)

Registration Rights Agreement, dated as of January 29, 2024, by and among Skye Bioscience, Inc. and the Investors named therein (Filed With SEC on January 29, 2024)

Exclusive License Agreement, dated November 30, 2023, by and between the Company and Tautomer Bioscience (Pty) Limited (Filed With SEC on December 5, 2023)

Offer to Sell, dated (Filed With SEC on December 5, 2023)

Form of Lock-Up Agreement (Filed With SEC on November 14, 2023)

Amendment No 1 to Amended and Restated 2014 Omnibus Incentive Plan (Filed With SEC on October 3, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on August 21, 2023)

Form of Secured Convertible Promissory Note issued by Skye Bioscience, Inc. to MFDI, LLC (Filed With SEC on August 21, 2023)

Common Stock Purchase Warrant issued by Skye Bioscience, Inc. to MFDI, LLC (Filed With SEC on August 21, 2023)

Securities Purchase Agreement, dated as of August 15, 2023, by and among Skye Bioscience, Inc. and the Investors named therein (Filed With SEC on August 21, 2023)

Registration Rights Agreement, dated as of August 15, 2023, by and among Skye Bioscience, Inc. and the Investors named therein (Filed With SEC on August 21, 2023)

Secured Note and Warrant Purchase Agreement, dated as of August 15, 2023, by and among Skye Bioscience, Inc. and MFDI, LLC (Filed With SEC on August 21, 2023)

Form of Indemnification Agreement (Filed With SEC on August 21, 2023)

Amended and Restated Office Lease, dated June 27, 2023, by and between ROIC California, LLC and Skye Bioscience, Inc (Filed With SEC on August 7, 2023)

Amendment to Executive Employment Agreement (Filed With SEC on May 12, 2023)

2022 Form of Warrant Issued to Former EHT Warrant Holders (Filed With SEC on March 31, 2023)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2023)

Master Transaction Agreement, dated February (Filed With SEC on February 23, 2023)

Second Amendment to the Verdlite SPA (Filed With SEC on February 15, 2023)

Amendment No. 1 to the Share Purchase Agreement (Filed With SEC on January 27, 2023)

Amendment No. 5 to Multi Draw Credit Agreement, dated December 30, 2022, by and between the Company and Sciences (Filed With SEC on January 6, 2023)

Registration Rights Agreement (Filed With SEC on December 19, 2022)

Amendment and Acknowledgement Agreement (Filed With SEC on November 23, 2022)

Form of Stock Option Award - For Canadian Optionees under Amended and Restated 2014 Omnibus Incentive Plan (Filed With SEC on November 14, 2022)

Share Purchase Agreement, dated November 8, 2022, by and between Emerald Health Therapeutics, Inc., 14428773 Canada Inc., Verdelite Sciences, Inc., Verdelite Property Holdings,... (Filed With SEC on November 14, 2022)

Third Amendment to Arrangement Agreement (Filed With SEC on October 19, 2022)

Loan Agreement and Note (Filed With SEC on October 19, 2022)

2022 Common Stock Warrant issued to Bear Creek Capital (Filed With SEC on August 15, 2022)

Form of Stock Option Agreement under 2014 Omnibus Incentive Plan (Filed With SEC on August 15, 2022)

Form of Stock Option Agreement under 2014 Omnibus Incentive Plan (ISO) (Filed With SEC on August 15, 2022)

Amendment No. 2 to (Filed With SEC on July 21, 2022)

Amendment No. 1 to Plan of Arrangement (Filed With SEC on June 17, 2022)

EHT Support Agreement (Filed With SEC on May 23, 2022)

Skye Support Agreement (Filed With SEC on May 23, 2022)

Form of Restricted Stock Unit Agreement under 2014 Omnibus Incentive Plan (Filed With SEC on March 28, 2022)

Notice of Option Amendment (Filed With SEC on March 28, 2022)

Restated and Amended License Agreement, dated as of May 24, 2019, by and between the Company and University of Mississippi, School of Pharmacy (UM 5050) (Filed With SEC on March 28, 2022)

Amendment No. 3 to the Amended and Restated Multi-Draw Credit Agreement, dated (Filed With SEC on March 28, 2022)

Exclusive Sponsored Research Agreement, dated October 12, 2021, by and between the Company and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on October 15, 2021)

Executive Employment Agreement, dated October 4, 2021, by and between the Company and Kaitlyn Arsenault (Filed With SEC on October 6, 2021)

Form of Series A Warrant (Filed With SEC on September 28, 2021)

Form of Pre-Funded Warrant (Filed With SEC on September 28, 2021)

Form of Placement Agent Warrant (Filed With SEC on September 28, 2021)

Form of Securities Purchase Agreement (Filed With SEC on September 28, 2021)

Form of Lock-up Agreement (Filed With SEC on September 28, 2021)

Collaborative Research Agreement, dated April 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on August 6, 2021)

Sublease Agreement, dated April 2021, by and between Skye Bioscience, Inc. and Emerald Health Pharmaceuticals, Inc (Filed With SEC on August 6, 2021)

Form of Letter Agreement (Filed With SEC on July 22, 2021)

Form of New Warrant (Filed With SEC on July 22, 2021)

Amendment No. 2 to Multi-Draw Credit Agreement (Filed With SEC on May 7, 2021)

Collaborative Research Agreement, dated January 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on March 2, 2021)

Separation and Release Agreement, dated August 7, 2020, by and between Emerald Bioscience, Inc. and Brian Murphy (Filed With SEC on August 12, 2020)

Employment Agreement, dated August 10, 2020, by and between Emerald Bioscience, Inc. and Punit Dhillon (Filed With SEC on August 12, 2020)

Amendment No. 2 to 2014 Omnibus Incentive Plan (Filed With SEC on August 12, 2020)

Form of Common Warrant (Filed With SEC on August 5, 2020)

Form of Pre-Funded Warrant (Filed With SEC on August 5, 2020)

Form of Securities Purchase Agreement, dated as of July 31, 2020, between the Company and certain purchasers set forth in the signature page thereto (Filed With SEC on August 5, 2020)

Placement Agency Agreement (Filed With SEC on July 28, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on July 28, 2020)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on July 28, 2020)

Form of Placement Agent Common Stock Purchase Warrant (Filed With SEC on July 28, 2020)

Form of Securities Purchase Agreement (Filed With SEC on July 28, 2020)

Amended and Restated Multi-Draw Credit Agreement, dated April 29, 2020, by and between Emerald Bioscience, Inc. and Emerald Health Sciences, Inc. Sciences, Inc (Filed With SEC on April 29, 2020)

Separation and Release Agreement, dated April 29, 2020, between Emerald Bioscience, Inc. and Doug Cesario (Filed With SEC on April 29, 2020)

Warrant Exercise Agreement, dated as of December 20, 2019, between the Company and Emerald Health Sciences (Filed With SEC on December 23, 2019)

Independent Contractor Services Agreement, dated as of December 19, 2019, between the Company and Dr. Avtar Dhillon (Filed With SEC on December 23, 2019)

Form of Warrant (Filed With SEC on November 21, 2019)

Form of Securities Purchase Agreement, dated as of November 20, 2019, between the Company and certain purchasers set forth in the signature page thereto (Filed With SEC on November 21, 2019)

Master Services Agreement, dated as of September 20, 2019, by and between EMBI Australia and Novotech (Australia) Pty Limited (Filed With SEC on November 14, 2019)

Employment Agreement, dated as of August 16, 2019, by and between the Company and Dr. Dennis D. Kim (Filed With SEC on October 23, 2019)

Start-Up Agreement, dated as of August 23, 2019, by and between the Company and Novotech (Filed With SEC on August 27, 2019)

First Amendment to Master Development and Clinical Supply Agreement, dated as of August 7, 2019 by and between the Company and Noramco (Filed With SEC on August 8, 2019)

Restated and Amended License Agreement, dated as of May 24, 2019 by and between the Company and UM (Filed With SEC on May 29, 2019)

Form of Warrant (Filed With SEC on March 14, 2019)

Master Development and Clinical Supply Agreement, dated February 26, 2019, by and between Nemus Bioscience, Inc. and Noramco, Inc (Filed With SEC on March 4, 2019)

Form of Warrant (Filed With SEC on October 12, 2018)

Multi-Draw Credit Agreement, dated October 5, 2018, by and between Nemus Bioscience, Inc. and Emerald Health Sciences, Inc (Filed With SEC on October 12, 2018)

Registration Rights Agreement, dated October 5, 2018, by and between Nemus Bioscience, Inc. and Emerald Health Sciences, Inc (Filed With SEC on October 12, 2018)

Amendment No. 1 to 2014 Omnibus Incentive Plan (Filed With SEC on October 12, 2018)

Letter Agreement, dated July 31, 2018, by and between Nemus Bioscience, Inc. and Albany Molecular Research Inc (Filed With SEC on August 1, 2018)

Employment Agreement, dated May 25, 2018, between Nemus Bioscience, Inc. and Douglas Cesario (Filed With SEC on June 1, 2018)

Stock Option Agreement, dated May 25, 2018, between Nemus Bioscience, Inc. and Douglas Cesario (Filed With SEC on June 1, 2018)

Separation and Release Agreement, dated April 30, 2018, between Nemus Bioscience, Inc. and Elizabeth Berecz (Filed With SEC on May 4, 2018)

Independent Contractor Termination Agreement and Release (Filed With SEC on March 19, 2018)

Independent Contractor Agreement (Filed With SEC on March 19, 2018)

Form of Restricted Stock Agreement, by and between Nemus Bioscience, Inc. and the Restricted Stockholders party thereto (Filed With SEC on January 22, 2018)

Securities Purchase Agreement, dated January 18, 2018, by and among Nemus Bioscience, Inc., Nemus and Emerald Health Sciences Inc (Filed With SEC on January 22, 2018)

Secured Promissory Note, dated December 28, 2017, by Nemus Bioscience, Inc., to Emerald Health Sciences Inc (Filed With SEC on January 3, 2018)

Security Agreement, dated December 28, 2017, by and among Nemus Bioscience, Inc., and Emerald Health Sciences Inc (Filed With SEC on January 3, 2018)

Form of Securities Purchase Agreement (Filed With SEC on November 2, 2017)

Form of Registration Rights Agreement (Filed With SEC on November 2, 2017)

Securities Purchase Agreement, dated May 3, 2017, between Nemus Bioscience, Inc. and Schneider Finance LLC (Filed With SEC on May 4, 2017)

License Agreement, dated January 10, 2017, between the Company and the University of Mississippi, School of Pharmacy (Filed With SEC on January 20, 2017)

Form of Lock-Up Agreement (Filed With SEC on January 10, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 29, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 29, 2016)

NEMUS BIOSCIENCE, INC. October 26, 2016 (Filed With SEC on October 27, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 26, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 26, 2016)

Letter Agreement with Albany Molecular Research Inc. dated February 5, 2016 (Filed With SEC on March 21, 2016)

License Agreement, dated December 14, 2015, between Nemus and the University of Mississippi, School of Pharmacy (Filed With SEC on December 18, 2015)

Form of restricted stock award agreement for Dr. Murphy and Ms. Berecz (Filed With SEC on October 22, 2015)

Form of Lock-Up Agreement (Filed With SEC on August 21, 2015)

Form of Warrant (Filed With SEC on August 20, 2015)

Form of Securities Purchase Agreement (Filed With SEC on August 20, 2015)

Form of Registration Rights Agreement (Filed With SEC on August 20, 2015)

Form of Warrant dated June 8, 2015 issued by Nemus Bioscience, Inc. to holder to purchase 10,000 shares of common stock (Filed With SEC on August 14, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 6, 2015)

Form of Securities Purchase Agreement by and between Nemus Bioscience, Inc. and the investors (Filed With SEC on June 3, 2015)

Form of Warrant dated April 25, 2015 issued by Nemus Bioscience, Inc. to holder to purchase 100,000 shares of common stock (Filed With SEC on May 13, 2015)

Form of Warrant dated April 29, 2015 issued by Nemus Bioscience, Inc. to holder to purchase 90,000 shares of common stock (Filed With SEC on May 13, 2015)

Form of Warrant dated April 26, 2015 issued by Nemus Bioscience, Inc. to holder to purchase 6,000 shares of common stock (Filed With SEC on May 13, 2015)

Form of Common Stock Purchase Warrant (Filed With SEC on April 7, 2015)

Form of Securities Purchase Agreement by and between Nemus Bioscience, Inc. and the investors (Filed With SEC on April 7, 2015)

Nemus Bioscience, Inc. Officer Change in Control Severance Plan (Filed With SEC on February 27, 2015)

INDEMNIFICATION AGREEEMENT (Filed With SEC on January 12, 2015)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on January 9, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 9, 2015)

Form of Warrants issued by Nemus to certain security holders to purchase an aggregate of 1,000,000 shares of commons stock (Filed With SEC on November 3, 2014)

Assignment and Assumption Agreement between the Registrant and LGT, Inc. dated October 31, 2014 (Filed With SEC on November 3, 2014)

Share Repurchase and Cancellation Agreement between the Registrant, Yosbani Mendez and Francisco Mendez. dated October 31, 2014 (Filed With SEC on November 3, 2014)

Form of Lock-up Agreement (Filed With SEC on November 3, 2014)

Nemus Bioscience Inc. 2014 Omnibus Incentive Plan (Filed With SEC on November 3, 2014)

Form of Stock Option Agreement under 2014 Omnibus Incentive Plan (Filed With SEC on November 3, 2014)

Memorandum of Understanding, dated July 31, 2013, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)

Option Agreement dated May 15, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)

Amendment dated June 26, 2014, to the Option Agreement dated May 15, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)

Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)

License Agreement, dated September 29, 2014, between Nemus and the University of Mississippi, School of Pharmacy (Filed With SEC on November 3, 2014)

Lease Agreement dated September 1, 2014 between University of Mississippi Research Foundation, Inc. and Nemus (Filed With SEC on November 3, 2014)

Center Tower Lease dated October 13, 2014, by and between Nemus and Center Tower Associates LLC (Filed With SEC on November 3, 2014)

Amendment dated August 15, 2014, to the Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)

Option Agreement dated October 15, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)

Second Amendment dated October 15, 2014, to the Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on October 17, 2014)

Category

Industry

Companies

Contracts

Emerald Bioscience, Inc. Contracts & Agreements